Netflix Rides Hiked Price Target, Pfizer Drug Hits a Snag, and 3 More Hot Stocks

  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Netflix (NASDAQ:NFLX): Netflix has been awarded with a generous price target hike from MKM Partners, based on the firm’s view that the streaming service’s international subscriber totals will surprise; MKM’s thesis on Netflix is more focused on global mass penetration than on pricing in the U.S. Netflix, now trading just shy of $320, has been hit with a $370 price target by the firm.

NFLX 20131001

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business